SciELO - Scientific Electronic Library Online

 
vol.40 número2Validez y fiabilidad de la escala de evaluación de riesgos para la alimentación y la nutrición (SCREEN II) en la sociedad turcaRelación del polimorfismo del gen de la resistina (rs7139228) con los niveles de resistina y el riesgo de síndrome metabólico en sujetos obesos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Nutr. Hosp. vol.40 no.2 Madrid mar./abr. 2023  Epub 05-Jun-2023

https://dx.doi.org/10.20960/nh.04435 

ORIGINAL PAPERS

Association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients: a prospective observational study

Asociación entre el índice glucemia-triglicéridos con la presencia de hígado graso no alcohólico y mortalidad en pacientes hospitalizados de avanzada edad: estudio observacional prospectivo

Xiaogang Wang1  2  , conception of the paper, implementing the program and acquiring the data, writing, interpretation of data analysis, drafting or review of the paper, approvement of this version for publication; Wei Zhou3  , performing of the statistical analysis, writing, interpretation of data analysis, drafting or review of the paper, approvement of this version for publication; Qianqian Song4  , finalized the paper, interpretation of data analysis, drafting or review of the paper, approvement of this version for publication; Ying Xie1  , implementing the program and acquiring the data, interpretation of data analysis, drafting or review of the paper, approvement of this version for publication

1Department of Endocrinology. The Second Affiliated Hospital of Soochow University. Suzhou, People's Republic of China

2Department of Endocrinology. Affiliated Hospital of Shandong Medical College (Linyi Geriatric Hospital). Linyi, People's Republic of China

3Department of Human Resources. Affiliated Hospital of Shandong Medical College (Linyi Geriatric Hospital). Linyi, People's Republic of China

4Department of Respiratory Diseases. Affiliated Hospital of Shandong Medical College (Linyi Geriatric Hospital). Linyi, People's Republic of China

Abstract

Introduction:

non-alcoholic fatty liver disease (NAFLD) is a disease in which there is excessive fat deposition in hepatocytes due to hepatoprotective factors.

Objectives:

to assess the association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients. To identify the TyG index as a predictive factor of NAFLD.

Methods:

this prospective observational study included elderly inpatients admitted to the Department of Endocrinology at the Linyi Geriatrics Hospital, Affiliated to Shandong Medical College, between August 2020 and April 2021. The TyG index was calculated according to an established formula: TyG = Ln [triglycerides (TG) (mg/dl) × Fasting plasma glucose (FPG) (mg/dl) / 2].

Result:

a total of 264 patients were enrolled, with 52 (19.7 %) cases occurred NAFLD. Multivariate logistic regression analysis showed that TyG (OR = 3.889; 95 % CI: 1.134-11.420; p = 0.014) and ALT (OR = 1.064; 95 % CI: 1.012-1.118; p = 0.015) were independently associated with the occurrence of NAFLD. Furthermore, receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of TyG was 0.727, with sensitivity = 80.4 % and specificity = 57.8 % at cut off = 8.71. A Cox proportional hazards regression model showed that, after adjusting for age, sex, smoking, drinking, hypertension, and type 2 diabetes TyG > 8.71 (HR = 3.191; 95 % CI: 1.347 to 7.560; p < 0.001) was an independent risk factor for mortality in the elderly.

Conclusions:

the TyG index can predict non-alcoholic fatty liver disease and mortality in elderly Chinese inpatients.

Keywords: Triglyceride-glucose index; Occurrence; Non-alcoholic fatty liver disease; Mortality; Prospective observational study

Resumen

Introducción:

la enfermedad del hígado graso no alcohólico (EHGNA) es una enfermedad en la que una cantidad excesiva de grasa se acumula en los hepatocitos debido a factores hepatoprotectores.

Objetivos:

evaluar la asociación entre el índice glucemia-triglicéridos con la presencia de hígado graso no alcohólico (EHGNA) y mortalidad en pacientes hospitalizados de avanzada edad. Identificar el índice TyG como factor predictivo de la EHGNA.

Métodos:

este estudio observacional y prospectivo incluyó a pacientes de avanzada edad hospitalizados en el Departamento de Endocrinología del Hospital de Geriatría de Linyi, Afiliado al Colegio Médico de Shandong, entre agosto de 2020 y abril de 2021. El índice TyG se calculó según una fórmula establecida: TyG = Ln [triglicéridos (TG) (mg/dl) × Glucosa en sangre en ayunas (FPG) (mg/dl) / 2].

Resultado:

se incluyeron 264 pacientes, con 52 (19,7 %) casos de EHGNA. El análisis de regresión logística multivariante mostró que el TyG (razón de momios (OR) = 3,889; intervalo de confianza del 95 %: 1,134-11,420; p = 0,014) y ALT (razón de momios (OR) = 1,064; intervalo de confianza del 95 %: 1,012-1,118; p = 0,015) se asociaban de forma independiente con la aparición de EHGNA. Además, el análisis de la curva de características operativas del receptor (ROC) mostró que el área bajo la curva (AUC) de TyG era de 0,727, con una sensibilidad del 80,4 % y una especificidad del 57,8 % en el punto de corte de 8,71. El modelo de regresión de riesgos proporcionales de Cox mostró que, tras ajustar por edad, sexo, tabaquismo, consumo de alcohol, hipertensión y diabetes tipo 2, un TyG > 8,71 (HR = 3,191; intervalo de confianza del 95 %: 1,347 a 7,560; p < 0,001) era un factor de riesgo independiente de mortalidad para los paciente de edad avanzada.

Conclusiones:

el índice TyG puede predecir la enfermedad del hígado graso no alcohólico y la mortalidad en pacientes chinos hospitalizados de avanzada edad.

Palabras clave: índice glucemia-triglicéridos; Presencia; Enfermedad del hígado graso no alcohólico; Mortalidad; Estudio observacional prospectivo

INTRODUCTION

Non-alcoholic fatty liver disease (NAFLD) is a disease in which there is excessive fat deposition in hepatocytes due to hepatoprotective factors other than a history of significant alcohol consumption, drug use, hepatitis C virus infection, or other diseases such as starvation (1). Fatty liver can cause liver damage that leads to inflammation (non-alcoholic steatohepatitis [or NASH]) or liver scarring (cirrhosis) (2). NAFLD is a common worldwide disease with a 10-30 % prevalence in different countries. NAFLD is also increasingly recognized as the cause of elevated levels of liver enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), or γ-glutamyl transferase (GGT) (3). Several studies have shown that NAFLD is a significant risk factor for peripheral vascular disease, diabetes mellitus, cardiovascular disease, and renal disease, which have serious consequences (4-6).

Insulin resistance (IR) (7,8) is the inadequate response of adipocytes, muscle cells, and hepatocytes to normal insulin concentrations when the pancreas has no pathological abnormality. The liver is one of the main sites for the control of metabolic homeostasis. Metabolic diseases such as IR, type 2 diabetes (T2D), dyslipidemia, and NAFLD are linked through molecular biochemistry and complex immune mechanisms (9,10). Hyperinsulinemia is caused by β-cell efforts to overcome IR by enhancing insulin release. High caloric intake impairs insulin receptor signaling, resulting in defective inhibition of FFA release from adipocytes and defective nitric oxide (NO) release (11). Thus, IR and inflammation form a vicious circle in the presence of lipotoxicity, each contributing to the other and accelerating the development of NAFLD and other metabolic disorders (12). In obese and lean subjects, high IR was found to be the most critical predictor of NAFLD (13). Studies have shown that serum insulin levels are strongly associated with ballooning and hepatic lobular inflammation (14).

The aforementioned studies suggest that IR increases the risk of NAFLD and that IR may cause steatosis (15-17). In addition, the triglyceride glucose (TyG) index, an early marker of IR, is considered a cheap and reliable proxy for IR (18). An elevated TyG index has been reported to reflect more severe IR and is associated with all-cause and cardiovascular disease-induced mortality (19). In recent years, the relationship between TyG and NAFLD has been a hot research topic. However, the relationship between the TyG index and NAFLD risk remains limited. Most studied populations are adolescents and middle-aged adults (20-22). To the best of our knowledge, the relationship between the TyG index, NAFLD, and mortality in older Chinese adults has not been reported.

Therefore, this study aimed to explore the association between triglyceride glucose index and the occurrence and mortality of NAFLD in elderly inpatients.

MATERIALS AND METHODS

STUDY DESIGN AND POPULATION

This prospective observational study included elderly inpatients admitted to the Department of Endocrinology at the Linyi Geriatrics Hospital Affiliated to Shandong Medical College between August 2020 and April 2021.

Inclusion criteria were: 1) diagnosis of NAFLD according to the guidelines proposed by the APWG guidelines (23); 2) age above 65 years; and 3) availability of liver ultrasound. Exclusion criteria were: 1) having hepatic viral infection, autoimmune hepatic disease, other chronic hepatic diseases, carcinomatous cachexia (concerning the clinical history), severe infections, acute myocardial infarction, and acute cerebral infarction; and 2) long-term use of steatogenic medications and exceptionally high alcohol intake (more than 140 g per week in men and more than 70 g per week in women).

The study was approved by the Ethics Committee of the Affiliated Hospital of Shandong Medical College (Linyi Geriatric Hospital) [ SDYZFSYY2020002] and was conducted by the Declaration of Helsinki. All patients signed an informed consent form to verify consent and compliance.

PROCEDURES

Using an ultrasound machine, trained sonographers performed liver ultrasound (Toshiba, Tokyo, Japan), and NAFLD was diagnosed by ultrasound imaging. The study objectives and experimental data were single-blinded to the sonographer. Images were acquired in a standard fashion, with the patient in the supine position with the right arm raised above the head.

Detailed medical history and lifestyle information, including age, sex, smoking, and drinking status, was confirmed by a trained physician from medical records. Current smoking status was defined as ‘yes' if the patients had smoked at least one cigarette per day or seven cigarettes per week in the past six months. Current drinking status was defined as ‘yes' if the subject had consumed alcohol at least once a week in the past six months. Blood pressure (BP) in the nondominant arm was measured in the seated position after 5 minutes of rest using an automated electronic instrument (OMRON HEM-752 FUZZY' Omron Corporation, Dalian, China). Three measurements were taken one minute apart, and the average of the three measurements was used for analysis. Measured BP above 140/90 mmHg or being treated with antihypertensive therapy was considered a criterion for hypertension. An experienced physician measured body height, weight, and waist circumference (WC) with an accuracy of 0.1 cm, 0.1 kg, and 0.1 cm, respectively, and participants wore light indoor clothing while standing without shoes. Body mass index (BMI) (kg/m2) was calculated as weight (kg) divided by height (m2). All patients fasted overnight before blood samples collection. Fasting plasma glucose (FPG), triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), hemoglobin A1c (HbA1c), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) measurements were analyzed and determined by an automated analyzer according to standard methods. TyG index was calculated according to the established formula: TyG = Ln [TG (mg/dl) × FPG (mg/dl) / 2].

Participants were followed up for six months, and survival was collected. Follow-up was conducted by telephone, and there were no missed visits.

STATISTICAL ANALYSIS

The SAS version 9.1 (SAS Institute, Cary, NC) was used for database management and statistical analysis. Data for continuous variables were expressed as mean ± standard deviation (SD), and data for categorical variables were expressed as numbers (percentages). The Kolmogorov-Smirnov test was used to test the normal distribution. Comparisons of means and proportions were performed using Student's t-test and the Chi-square test, respectively. In addition, logistic regression analysis was used to evaluate the association between the TyG index and NAFLD. Receiver operating characteristic (ROC) curves were used to determine the optimal TyG index cut off point for predicting NAFLD. Cox regression models with hazard ratios (HRs) and 95 % CIs were conducted to examine the association between TyG index and mortality. A two-sided p < 0.05 was considered statistically significant.

PATIENT AND PUBLIC INVOLVEMENT

Patients or the public WERE NOT involved in our research design, conduct, reporting, or dissemination plans.

RESULTS

A total of 264 patients were enrolled (mean age, 86.6 ± 6.4 years; male/female, 203/61), with 52 (19.7 %) of them having NAFLD. There were significant differences in TG, ALT, TyG index, BMI, and WC between NAFLD and non-NAFLD patients (all p < 0.05). However, age, sex, smoking status, alcohol consumption status, SBP, DBP, HbA1c, FPG, TC, LDL-c, HDL-c, AST, T2D, and hypertension between NAFLD and non-NAFLD patients were comparable (all p > 0.05). Moreover, mortality in NAFLD patients (20.8 %) was significantly higher than in non-NAFLD (8.8 %) patients (p = 0.006) (Table I). With the increase of the TyG index tertile, the occurrence of NAFLD increased significantly (ptrend < 0.001) (Fig. 1).

Table I. Characteristics of NAFLD and Non-NAFLD in older adults. 

SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; TC: total cholesterol; TG: triglyceride; LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TyG: triglyceride and glucose index; BMI: body mass index; WC: waist circumference; T2D: type 2 diabetes.

Figure 1. The difference in the prevalence of NAFLD according to the TyG index tertile. 

A multivariate logistic regression analysis showed that TyG (OR = 3.889; 95 % CI: 1.134-11.420; p = 0.014) and ALT (OR = 1.064; 95 % CI: 1.012-1.118; p = 0.015) were independent risk factors for NAFLD (Fig. 2 and Table II). ROC curve analysis of the TyG index for NAFLD showed an AUC of 0.727 [(p < 0.001); 95 % CI: 0.645 to 0.809], with sensitivity = 80.4 %, and specificity = 57.8 % at cut off = 8.71 (Fig. 3).

Figure 2. Independent factors for NAFLD by multivariable logistic regression analysis. BMI: body mass index; WC: waist circumference; ALT: alanine aminotransferase; TyG: triglyceride and glucose index. 

Table II. Risk factors associated with NAFLD. 

BMI: body mass index; WC: waist circumference; ALT: alanine aminotransferase; TyG: triglyceride and glucose index.

Figure 3. ROC curve analysis of TyG for NAFLD. AUC = 0.727 (p < 0.001); 95 % CI: 0.645-0.809; TyG cut off point: 8.71; Youden index: 0.342; sensitivity: 80.4 %; specificity: 57.8 %. 

Furthermore, the Kaplan-Meier survival curve for TyG > 8.71 was significantly higher than that of the TyG < 8.71 group (p < 0.001) (Fig. 4). A Cox proportional hazard regression model showed that, after adjusting for age, sex, smoking, drinking, hypertension, and T2D, TyG > 8.71 (HR = 3.191; 95 % CI: 1.347 to 7.560; p < 0.001) was an independent risk factor for mortality (Fig. 5).

Figure 4. Survival curves of the study population according to the TyG cut off point. Log-rank test (p < 0.001). 

Figure 5. Association between TyG and mortality (6-month follow-up) according to Cox regression models adjusted for potential confounders. Adjusted for age, sex, smoking, drinking, hypertension, and T2D. 

DISCUSSION

This study suggested that the TyG index may be associated with the occurrence and mortality of NAFLD in elderly inpatients. Therefore, the TyG index may be a potential and non-invasive indicator to identify NAFLD.

Several studies have confirmed that IR is closely associated with the development and progression of NAFLD (24,25). Elevated IR can lead to changes from normal liver to NAFLD to non-alcoholic steatohepatitis (NASH) (20). The TyG index is associated with IR in muscle (26), and an increase in IR in muscle leads to glucose flow to the liver and a relatively low IR in the liver leading to fatty liver (27). Therefore, the TyG index is an inexpensive and reliable IR surrogate that plays a vital role in the development and progression of NAFLD (28). To our knowledge, our study is the first to focus on the effect of the TyG index on morbidity and mortality in NAFLD in Chinese elderly people, and elevated TyG remained an independent risk factor for death in the Chinese elderly patient population after adjusting for potential confounders. A retrospective cohort study showed that after adjusting for possible confounders (including sex, BMI, SBP, DBP, HbA1c, ALT, AST, and HDL-c), the prevalence of NAFLD in older adults aged 60 years or more senior was 12.1 % (29), which was lower than in our study (19.7 %). A higher TyG index has also been reported to be associated with a higher risk of NAFLD, which is consistent with our results (29). In this study, we identified an optimal TyG index threshold of 8.71 for predicting NAFLD morbidity in older Chinese adults, which is similar to other research (29), taking race, sex, age, and sample size into account.

This study also has some limitations. First, although ultrasonography showed high sensitivity and specificity in the diagnosis of moderate and severe fatty liver (29), it is still not accurate enough compared to liver biopsy-based diagnosis and may lead to the underdiagnosis of mild fatty liver. Therefore, we may only reveal a significant association between TyG index and moderate and severe fatty liver. Second, the sample size of this study was small, and the data were not analyzed according to gender. Finally, all participants in the study were Chinese, so the results may not apply to other ethnic groups.

In conclusion, the TyG index may be associated with the occurrence of NAFLD and mortality in elderly inpatients. TyG index may be a valuable indicator for NAFLD prediction and help prevent the development of NAFLD at an early stage.

Acknowledgements:

we thank all the teams involved in the development and implementation of the study.

REFERENCES

1. Abdelmalek MF. Nonalcoholic fatty liver disease: another leap forward. Nat Rev Gastroenterol Hepatol 2021;18(2):85-6. DOI: 10.1038/s41575-020-00406-0 [ Links ]

2. Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology 2020;158(7):1851-64. DOI: 10.1053/j.gastro.2020.01.052 [ Links ]

3. Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, et al. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients 2020;12(9). DOI: 10.3390/nu12092762 [ Links ]

4. Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol 2015;35(5):1284-91. DOI: 10.1161/atvbaha.114.305200 [ Links ]

5. Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 2018;75(18):3313-27. DOI: 10.1007/s00018-018-2860-6 [ Links ]

6. Hagström H, Nasr P, Ekstedt M, Kechagias S, Stål P, Bedossa P, et al. SAF score and mortality in NAFLD after up to 41 years of follow-up. Scand J Gastroenterol 2017;52(1):87-91. DOI: 10.1080/00365521.2016.1230779 [ Links ]

7. Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 2021;119:154766. DOI: 10.1016/j.metabol.2021.154766 [ Links ]

8. Onyango AN. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance. Oxid Med Cell Longev 2018;2018:4321714. DOI: 10.1155/2018/4321714 [ Links ]

9. Lindenmeyer CC, McCullough AJ. The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. Clin Liver Dis 2018;22(1):11-21. DOI: 10.1016/j.cld.2017.08.003 [ Links ]

10. Kleinert M, Clemmensen C, Hofmann SM, Moore MC, Renner S, Woods SC, et al. Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol 2018;14(3):140-62. DOI: 10.1038/nrendo.2017.161 [ Links ]

11. Gambino R, Bugianesi E, Rosso C, Mezzabotta L, Pinach S, Alemanno N, et al. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. Int J Mol Sci 2016;17(4):479. DOI: 10.3390/ijms17040479 [ Links ]

12. Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci 2020;21(2). DOI: 10.3390/ijms21020494 [ Links ]

13. Huang JF, Tsai PC, Yeh ML, Huang CF, Huang CI, Hsieh MH, et al. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. J Formos Med Assoc 2020;119(1 Pt 1):89-96. DOI: 10.1016/j.jfma.2019.03.014 [ Links ]

14. Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, et al. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients. J Gastroenterol 2018;53(12):1261-75. DOI: 10.1007/s00535-018-1472-0 [ Links ]

15. Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. Jama 2020;323(12):1175-83. DOI: 10.1001/jama.2020.2298 [ Links ]

16. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15(1):11-20. DOI: 10.1038/nrgastro.2017.109 [ Links ]

17. Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol 2019;71(4):793-801. DOI: 10.1016/j.jhep.2019.06.021 [ Links ]

18. Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG Index Predicts Progression of Coronary Artery Calcification. Diabetes Care 2019;42(8):1569-73. DOI: 10.2337/dc18-1920 [ Links ]

19. Liu XC, He GD, Lo K, Huang YQ, Feng YQ. The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population. Front Cardiovasc Med 2020;7:628109. DOI: 10.3389/fcvm.2020.628109 [ Links ]

20. Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2019;16(6):377-86. DOI: 10.1038/s41575-019-0144-8 [ Links ]

21. Mohd Nor NS, Lee S, Bacha F, Tfayli H, Arslanian S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes 2016;17(6):458-65. DOI: 10.1111/pedi.12303 [ Links ]

22. Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol 2019;2019:5121574. DOI: 10.1155/2019/5121574 [ Links ]

23. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007;22(6):775-7. DOI: 10.1111/j.1440-1746.2007.05002.x [ Links ]

24. Sung KC, Lee MY, Lee JY, Lee SH, Kim YB, Song WJ, et al. Natural course of fatty liver in 36,195 South Korean adults. Sci Rep 2019;9(1):9062. DOI: 10.1038/s41598-019-44738-7 [ Links ]

25. Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol 2018;17(1):41. DOI: 10.1186/s12933-018-0692-1 [ Links ]

26. Kato K, Takeshita Y, Misu H, Zen Y, Kaneko S, Takamura T. Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. J Diabetes Investig 2015;6(2):158-63. DOI: 10.1111/jdi.12271 [ Links ]

27. Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis 2017;16(1):15. DOI: 10.1186/s12944-017-0409-6 [ Links ]

28. Huanan C, Sangsang L, Amoah AN, Yacong B, Xuejiao C, Zhan S, et al. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China. BMJ Open 2020;10(11):e039804. DOI: 10.1136/bmjopen-2020-039804 [ Links ]

29. Simental-Mendía LE, Simental-Mendía E, Rodríguez-Hernández H, Rodríguez-Morán M, Guerrero-Romero F. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women. Ann Hepatol 2016;15(5):715-20. DOI: 10.5604/16652681.1212431 [ Links ]

A data sharing statement:

the datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Funding:this project was not funded by any organization.

Ethics statement:the study was approved by the Ethics Committee of the Affiliated Hospital of Shandong Medical College (Linyi Geriatric Hospital) [ SDYZFSYY2020002] and was conducted in accordance with the Declaration of Helsinki. All patients signed an informed consent form to verify consent and compliance.

Wang X, Zhou W, Song Q, Xie Y. Association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients: a prospective observational study. Nutr Hosp 2023;40(2):319-324

Received: July 14, 2022; Accepted: December 18, 2022

Correspondence: Ying Xie. Department of Endocrinology. The Second Affiliated Hospital of Soochow University. Sanxiang Road, 1055. Gusu District. Suzhou 215004, Jiangsu. People's Republic of China e-mail: 13013883877@126.com

Conflicts of interest:

the authors declare that they have no conflicts of interest.

Contributorship statement:

author XGW conceived the paper. XGW and YX contributed to implementing the program and acquiring the data. WZ performed the statistical analysis. XGW and WZ wrote the paper. QQS finalized the paper. All authors contributed to the interpretation of data analysis, drafted or reviewed the paper, and approved this version for publication.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License